The potential role of boswellic acids in cancer prevention and treatment
作者： Nand Kishor Roy , Anindita Deka , Devivasha Bordoloi , Srishti Mishra , Alan Prem Kumar
DOI: 10.1016/J.CANLET.2016.04.017
关键词: Specificity protein 1 、 Bioinformatics 、 CCAAT/enhancer binding protein alpha 、 Limiting 、 Beta-boswellic acid 、 Biology 、 Anticarcinogenic Agents 、 Cancer prevention 、 Immunology 、 Boswellic acid 、 Cancer
摘要: Despite the extensive research carried out in field of cancer therapeutics, is one most dreadful diseases world with no definitive treatment to date. The key attributes responsible for this are various limiting factors associated conventional chemotherapeutics that primarily include adverse side-effects and development chemoresistance. Hence, there an utter need find compounds highly safe efficacious prevention cancer. Boswellic acid, a group pentacyclic compounds, seems be promising enough due its inherent anti-cancerous properties. Considering perspective, present review highlights established studies related anti-cancer potential boswellic acid against different types. molecular mechanisms underlying targets accountable potent effect also discussed. Overall, projects pieces evidence reveal as suitable candidate can appropriately developed designed into drug.
curtin.edu.au参考文章(92)
John Cook, Margreet C M Vissers, Anitra C Carr, Relief from cancer chemotherapy side effects with pharmacologic vitamin C. The New Zealand Medical Journal. ,vol. 127, pp. 66- 70 ,(2014)
Frank E Koehn, Guy T Carter, Rediscovering natural products as a source of new drugs. Discovery Medicine. ,vol. 5, pp. 159- 164 ,(2005)
Gerhard Hamilton, Barbara Rath, A short update on cancer chemoresistance Wiener Medizinische Wochenschrift. ,vol. 164, pp. 456- 460 ,(2014) , 10.1007/S10354-014-0311-Z
Reinhard Saller, Katarina Hostanska, Gerhard Daum, Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Research. ,vol. 22, pp. 2853- 2862 ,(2002)
M. Winking, S. Sarikaya, A. Rahmanian, A. Jödicke, D.-K. Böker, Boswellic acids inhibit glioma growth: a new treatment option? Journal of Neuro-oncology. ,vol. 46, pp. 97- 103 ,(2000) , 10.1023/A:1006387010528
Simon Kirste, Markus Treier, Sabine Jolie Wehrle, Gerhild Becker, Mona Abdel-Tawab, Kathleen Gerbeth, Martin Johannes Hug, Beate Lubrich, Anca-Ligia Grosu, Felix Momm, Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial. Cancer. ,vol. 117, pp. 3788- 3795 ,(2011) , 10.1002/CNCR.25945
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
Tatiana Syrovets, Berthold Büchele, Christine Krauss, Yves Laumonnier, Thomas Simmet, Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-α Induction in Monocytes by Direct Interaction with IκB Kinases The Journal of Immunology. ,vol. 174, pp. 498- 506 ,(2005) , 10.4049/JIMMUNOL.174.1.498
E.-R. Sailer, H. Safayhi, H. P. T. Ammon, MECHANISM OF 5-LIPOXYGENASE INHIBITION BY ACETYL-11-KETO-BETA -BOSWELLIC ACID Molecular Pharmacology. ,vol. 47, pp. 1212- 1216 ,(1995)
Subash C. Gupta, Ramaswamy Kannappan, Simone Reuter, Ji Hye Kim, Bharat B. Aggarwal, Chemosensitization of tumors by resveratrol. Annals of the New York Academy of Sciences. ,vol. 1215, pp. 150- 160 ,(2011) , 10.1111/J.1749-6632.2010.05852.X